scholarly article | Q13442814 |
P356 | DOI | 10.1210/ENDO-106-1-323 |
P698 | PubMed publication ID | 7349962 |
P2093 | author name string | Johnson LR | |
Dembinski AB | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 6 | |
P304 | page(s) | 323-328 | |
P577 | publication date | 1980-01-01 | |
P1433 | published in | Endocrinology | Q3054009 |
P1476 | title | Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin | |
P478 | volume | 106 |
Q53627618 | Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice. |
Q70583343 | Administration of caerulein to rats promotes antral epithelial cell renewal |
Q72076199 | An experimental study on the effects of selected drugs on pancreatic regeneration after partial pancreatectomy |
Q41694806 | CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium |
Q34357474 | CCK-independent mTORC1 activation during dietary protein-induced exocrine pancreas growth |
Q41781940 | Characterisation of gastrin receptors on a rat pancreatic acinar cell line (AR42J). A possible model for studying gastrin mediated cell growth and proliferation |
Q40789549 | Cholecystokinin activation of 70-kDa S6 kinase in exocrine pancreas |
Q72400503 | Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer |
Q33816883 | Cholecystokinin and pancreatic cancer: the chicken or the egg? |
Q69522747 | Cholecystokinin influences pancreatic trophism following total gastrectomy in rats |
Q69429797 | Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas |
Q42823811 | Cholecystokinin receptors in human pancreatic cancer cell lines |
Q68581002 | Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 |
Q73187449 | Chronic diversion of bile to the urinary bladder induces pancreatic growth in dogs |
Q72718457 | Comparison of 3-isobutyl-1-methylxanthine-induced accumulation of putrescine in rat pancreas and liver |
Q68587617 | Dissimilar trophic effects of cerulein and xenopsin on the rat pancreas |
Q43183826 | Effect of chronic bombesin on pancreatic size, composition and secretory function in the rat. |
Q33774309 | Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster |
Q43971027 | Effect of hypergastrinemia on pancreatic carcinogenesis |
Q67690056 | Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat |
Q42716127 | Effects of calcium mediated secretagogues on the growth of pancreatic acinar cells in vitro |
Q41660160 | Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells |
Q42457331 | Effects of gastric fundectomy and antrectomy on the exocrine pancreas in the hamster |
Q72643728 | Effects of gastrointestinal hormones on pancreatic growth |
Q36411535 | Effects of secretin on extracellular GABA and other amino acid concentrations in the rat hippocampus |
Q43779524 | Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy |
Q42068840 | Enteroendocrine cells in the developing opossum small intestine and colon |
Q45841809 | Establishment and characterization of rat pancreatic beta cell lines transformed by simian virus 40. |
Q39378866 | Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. |
Q39629924 | Feeding the premature and compromised infant: gastrointestinal considerations |
Q67692285 | Gastrin affects enzyme activity and gene expression in the aging rat pancreas |
Q88189128 | Gastrin and Gastric Cancer |
Q40887550 | Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells |
Q90639198 | Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes |
Q64038852 | Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines |
Q37246912 | Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression |
Q41464257 | Hormonal stimulation in the exocrine pancreas results in coordinate and anticoordinate regulation of protein synthesis |
Q36209187 | Hormone-induced protein phosphorylation. II. Localization to the ribosomal fraction from rat exocrine pancreas and parotid of a 29,000-dalton protein phosphorylated in situ in response to secretagogues |
Q69448879 | Inactivation of cholecystokinin octapeptide by normal and cirrhotic liver in rats |
Q43721752 | Increased incidence of pancreatic neoplasia in pernicious anemia |
Q48874031 | Influence of food deprivation on intestinal cholecystokinin and somatostatin |
Q42487393 | Influence of obstructive jaundice on pancreatic growth and on basal plasma levels of cholecystokinin and gastrin in rats |
Q70155764 | Influence of pancreatic neurotomy on regeneration of residual pancreas after major pancreatectomy in rats |
Q36245969 | Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. |
Q68325503 | Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide |
Q41827161 | Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion |
Q72575174 | Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts |
Q33902109 | Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells |
Q35885162 | Pancreatic growth and cell turnover in the rat fed raw soya flour |
Q43183791 | Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. |
Q34376891 | Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat |
Q72391131 | Phosphorylation of 3 particulate proteins in rat pancreatic acini in response to vasoactive intestinal peptide (VIP), secretin and cholecystokinin (CCK-8) |
Q72073849 | Postnatal development of circulating cholecystokinin and secretin, pancreatic growth, and exocrine function in guinea pigs |
Q36029262 | Potentiation of azaserine by cholestyramine in the rat |
Q67679274 | Proliferative Response of Different Exocrine Pancreatic Cell Types to Hormonal Stimuli: II. Effects of Long-Term Secretin Administration |
Q51654439 | Refeeding of mice after fasting stimulates cell renewal in the gall bladder epithelium. |
Q67692281 | Secretagogue induction of cell differentiation in pancreatic acinar cells in vitro |
Q34976655 | Secretin as a neuropeptide. |
Q73325389 | Secretin, its discovery, and the introduction of the hormone concept |
Q33728680 | Signaling pathways mediating gastrin's growth-promoting effects |
Q44134075 | Small bowel bypass prevents the trophic action of cholecystokinin on the rat pancreas |
Q40393295 | Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors |
Q47441086 | Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. III. Changes in DNA synthesis and mitotic activity |
Q42449654 | The effect of fasting and cholecystokinin stimulation on normal and neoplastic tissue in the rat pancreas |
Q69408230 | The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa) |
Q51653228 | The influence of starvation on intestinal cholecystokinin‐like activity and pancreatic growth |
Q34429213 | The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease |
Q28573158 | The secretin gene: evolutionary history, alternative splicing, and developmental regulation |
Q44419321 | Treatment for Hyperglycemia Promotes Pancreatic Regeneration in Rats Without CCK-1 Receptor Gene Expression |
Q34598135 | Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone |
Q72382853 | Treatment with Secretin and a Cholecystokinin-Like Peptide in Patients with Pancreatic Cancer |
Search more.